v3.26.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net (loss) income $ (4,099,467) $ 1,129,223
Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities:    
Bad debt (recovery) expense (2,954) 5,990
Amortization expense 723,787 271,966
Provision for refund liability 108,402 955,743
Provision for credit losses on other receivables 739,773
Deferred tax benefit (1,298,111) (66,547)
Interest income (31,998) (31,998)
Stock-based compensation expense 1,325,882 1,201,134
Changes in operating assets and liabilities:    
Accounts receivable (7,787,065) 359,982
Other receivables (71,444) (3,354,582)
Prepaid expenses and other assets 798,039 (561,907)
Operating lease right-of-use assets and liabilities, net (1,211) 37
Accounts payable and accrued expenses 4,364,800 2,269,897
Income taxes payable (170,309)
Other current liabilities (1,000,000)
Net cash (used in) provided by operating activities (6,231,567) 2,008,629
CASH FLOWS FROM INVESTING ACTIVITIES:    
Development of software (959,123) (1,613,372)
Net cash used in investing activities (959,123) (1,613,372)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from issuance of common stock in connection with private investment in public equity financing, net of placement agent fees and escrow agent fees 6,381,000
Payments of deferred offering costs (243,608) (106,339)
Contributions from noncontrolling interests 71,428
Taxes paid related to net share settlement of equity awards (173,071)
Net cash provided by (used in) financing activities 6,035,749 (106,339)
(Decrease) increase in cash and cash equivalents (1,154,941) 288,918
Cash and cash equivalents, beginning of period 7,669,754 7,849,248
Cash and cash equivalents, end of period 6,514,813 8,138,166
Supplemental disclosures of cash flow information:    
Cash paid for interest
Cash paid for income taxes 10,035 625,323
Summary of noncash investing and financing activities:    
Accrued deferred offering costs included in accounts payable and accrued expenses 215,911
Accrued development of software included in accounts payable and accrued expenses 430,386 265,243
Reclassification of deferred offering costs to additional paid-in capital upon private investment in public equity financing 527,910
Stock-based compensation capitalized for software development $ 19,454